Targeted agents for patients with advanced/metastatic pancreatic cancer: A protocol for systematic review and network meta-analysis

BACKGROUND: Pancreatic cancer (PC) is a devastating malignant tumor. Although surgical resection may offer a good prognosis and prolong survival, approximately 80% patients with PC are always diagnosed as unresectable tumor. National Comprehensive Cancer Network's (NCCN) recommended gemcitabine...

Descripción completa

Detalles Bibliográficos
Autores principales: Di, Baoshan, Pan, Bei, Ge, Long, Ma, Jichun, Wu, Yiting, Guo, Tiankang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895402/
https://www.ncbi.nlm.nih.gov/pubmed/29595634
http://dx.doi.org/10.1097/MD.0000000000010115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895402/
https://www.ncbi.nlm.nih.gov/pubmed/29595634
http://dx.doi.org/10.1097/MD.0000000000010115

Ejemplares similares